Abstract
Background and objective: Multiple drug use is common among old, frail nursing home residents who are, as a consequence, susceptible to adverse effects and drug interactions. This study uses the updated Beers criteria for potentially inappropriate drug (PID) use in older adults to determine the extent and nature of PIDs in older nursing home residents in Helsinki, Finland. The study also uses the Swedish, Finnish, INteraction X-referencing (SFINX) interaction database to assess the possibility of clinically significant class D (“clinically significant interaction, and the combination should be avoided”) drug-drug interactions (DDIs) in the same population.
Methods: This study is a cross-sectional assessment of all nursing home residents aged ≥65 years in Helsinki. The residents’ demographic information and medical data were collected from medical charts in February 2003.
Results: Of all nursing home residents in Helsinki, 82% (n = 1987) were eligible for analysis. Their mean age was 83.7 (SD 7.7) years, 80.7% were female and 69.5% were diagnosed with dementia. The mean number of drugs given on a regular basis per resident was 7.9 (SD 3.6) per day. Of the study population, 34.9% regularly used at least one PID. Residents taking PIDs were more likely to be taking psychotropic medication and to be taking nine or more drugs daily, and less likely to have a diagnosis of dementia, than patients not taking PIDs. The three most prevalent PIDs were: (i) short-acting benzodiazepines in greater than recommended doses (13.9% of all residents), of which temazepam >15 mg/day was the most commonly used agent and, indeed, the most common PID (taken by 13.5% of all residents); (ii) hydroxyzine (7.1%); and (iii) nitrofurantoin (6.3%). Together, these three PIDs accounted for 76.9% of all PID use. Of all residents, 4.8% were susceptible to a clinically significant DDI. The most common potential DDIs were related to the use of potassium-sparing diuretics, carbamazepine and codeine. Compared with residents not exposed to potential DDIs, residents exposed to potential DDIs were more likely to be younger, to have a prior history of stroke, to be taking psychotropics, to be taking nine or more drugs daily and to be taking PIDs.
Conclusion: Use of PIDs is very common among nursing home residents, and this increases the likelihood of DDIs. Monitoring patients for PID use and potential drug interactions could increase the quality of prescribing.
Similar content being viewed by others
References
Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents: UCLA Division of Geriatric Medicine. Arch Intern Med 1991 Sep; 151(9): 1825–32
Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997 Jul 28; 157(14): 1531–6
Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts [published erratum appears in Arch Intern Med 2004 Feb 9; 164 (3): 298]. Arch Intern Med 2003 Dec 8–22; 163(22): 2716–24
McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997 Feb 1; 156(3): 385–91
Naugler CT, Brymer C, Stolee P, et al. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 2000; 7(2): 103–7
Lääkeaineinteraktiot SFINX [online]. Available from URL: http://www.terveysportti.fi/ [Accessed 2008 Jul 11]
Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007 Jul 14; 370(9582): 173–84
Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992 Oct 15; 117(8): 684–9
Williams B, Betley C Inappropriate use of nonpsychotropic medications in nursing homes. J Am Geriatr Soc 1995 May; 43(5): 513–9
Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health 1997 Mar; 87(3): 404–9
Dhall J, Larrat EP, Lapane KL. Use of potentially inappropriate drugs in nursing homes. Pharmacotherapy 2002 Jan; 22(1): 88–96
Lane CJ, Bronskill SE, Sykora K, et al. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc 2004 Jun; 52(6): 861–6
Gray SL, Hedrick SC, Rhinard EE, et al. Potentially inappropriate medication use in community residential care facilities. Ann Pharmacother 2003 Jul–Aug; 37(7–8): 988–93
Lau DT, Kasper JD, Potter DE, et al. Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics. Health Serv Res 2004 Oct; 39(5): 1257–76
Raivio MM, Laurila JV, Strandberg TE, et al. Use of inappropriate medications and their prognostic significance among inhospital and nursing home patients with and without dementia in Finland. Drugs Aging 2006; 23(4): 333–43
Hosia-Randell H, Pitkälä K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland [published erratum appears in Drugs Aging 2005; 22 (11): 965]. Drugs Aging 2005; 22(9): 793–800
Hosia-Randell H, Suominen M, Muurinen S, et al. Use of laxatives among older nursing home residents in Helsinki, Finland. Drugs Aging 2007; 24(2): 147–54
Alanen HM, Finne-Soveri H, Noro A, et al. Use of antipsychotics among nonagenarian residents in long-term institutional care in Finland. Age Ageing 2006 Sep; 35(5): 508–13
Alanen HM, Finne-Soveri H, Noro A, et al. Use of antipsychotic medications among elderly residents in long-term institutional care: a three-year follow-up. Int J Geriatr Psychiatry 2006 Mar; 21(3): 288–95
Raivio MM, Laurila JV, Strandberg TE, et al. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry 2007 May; 15(5): 416–24
Morris JN, Hawes C, Fries BE, et al. Designing the national Resident Assessment Instrument for nursing homes. Gerontologist 1990 Jun; 30(3): 293–307
Noro A, Finne-Soveri H, Björkgren M, et al. Quality and productivity in institutional care for elderly residents: benchmarking with the RAI. Helsinki: National Research and Development Centre for Welfare and Health (STAKES), 2005
Sjöqvist F. A new classification system of drug interactions [abstract no. 377]. Eur J Clin Pharmacol 1997; 52 Suppl.: A126
Suominen M, Muurinen S, Routasalo P, et al. Malnutrition and associated factors among aged residents in all nursing homes in Helsinki. Eur J Clin Nutr 2005 Apr; 59(4): 578–83
Burrows AB, Morris JN, Simon SE, et al. Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing 2000 Mar; 29(2): 165–72
Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001 Feb; 49(2): 200–9
Gardner MJ, Altman DG, editors. Statistics with confidence: confidence intervals and statistical guidelines. 1st ed. London: BMJ Books, 1989
Pharmaca Fennica. Helsinki: Lääketietokeskus, 2007
Kunin CM. Inappropriate medication use in older adults: does nitrofurantoin belong on the list for the reasons stated [letter]? Arch Intern Med 2004 Aug 9–23; 164(15): 1701
Niwata S, Yamada Y, Ikegami N. Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities. BMC Geriatr 2006; 6: 1
Nygaard HA, Naik M, Ruths S, et al. Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents. The Bergen district nursing home (BEDNURS) study. Eur J Clin Pharmacol 2003 Sep; 59(5–6): 463–9
Perri 3rd M, Menon AM, Deshpande AD, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005 Mar; 39(3): 405–11
Lau DT, Kasper JD, Potter DE, et al. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005 Jan 10; 165(1): 68–74
Wagner AK, Ross-Degnan D, Gurwitz JH, et al. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med 2007 Jan 16; 146(2): 96–103
Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007 Jul 14; 370(9582): 185–91
Astrand B, Astrand E, Antonov K, et al. Detection of potential drug interactions: a model for a national pharmacy register. Eur J Clin Pharmacol 2006 Sep; 62(9): 749–56
Pharmaceutical specialities in Sweden [in Swedish; online]. Available from URL: http://www.fass.se/ [Accessed 2008 Jul 11]
Bjorkman IK, Fastbom J, Schmidt IK, et al. Pharmaceutical Care of the Elderly in Europe Research (PEER) Group: drug-drug interactions in the elderly. Ann Pharmacother 2002 Nov; 36(11): 1675–81
Acknowledgements
No sources of funding were used to assist in the preparation of this study. The authors have no conflicts of interest that are directly relevant to the content of this study.
The authors give their warmest thanks to the City of Helsinki.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hosia-Randell, H.M.V., Muurinen, S.M. & Pitkälä, K.H. Exposure to Potentially Inappropriate Drugs and Drug-Drug Interactions in Elderly Nursing Home Residents in Helsinki, Finland. Drugs Aging 25, 683–692 (2008). https://doi.org/10.2165/00002512-200825080-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200825080-00005